Prevalence of Hyperaldosteronism in Primary Care Patients with Resistant Hypertension

References

1. 1.↵
   1. Calhoun DA,
   2. Jones D,
   3. Textor S,
   4. et al

   . Resistant hypertension: Diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation 2008;117(25):e510–26.

   OpenUrlAbstract/FREE Full Text
2. 2.↵
   1. Nishikawa T,
   2. Saito J,
   3. Omura M

   . Is primary aldosteronism rare or common among hypertensive patients? Hypertens Res 2007;30(2):103–4.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Sywak M,
   2. Pasieka JL

   . Long-term follow-up and cost benefit of adrenalectomy in patients with primary hyperaldosteronism. Br J Surg 2002;89(12):1587–93.

   OpenUrlCrossRefPubMedWeb of Science
4. 4.↵
   1. Funder JW,
   2. Carey RM,
   3. Fardella C,
   4. et al

   . Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2008;93(9):3266–81.

   OpenUrlCrossRefPubMedWeb of Science
5. 5.↵
   1. Arlt W

   . A detour guide to the endocrine society clinical practice guideline on case detection, diagnosis and treatment of patients with primary aldosteronism. Eur J Endocrinol 2010;162(3):435–8.

   OpenUrlFREE Full Text
6. 6.↵
   1. Mosso L,
   2. Carvajal C,
   3. Gonzalez A,
   4. et al

   . Primary aldosteronism and hypertensive disease. Hypertension 2003;42(2):161–5.

   OpenUrlAbstract/FREE Full Text
7. 7.↵
   1. Jansen PM,
   2. Boomsma F,
   3. van den Meiracker AH

   , Dutch ARRAT Investigators. Aldosterone-to-renin ratio as a screening test for primary aldosteronism–the Dutch ARRAT study. Neth J Med 2008;66(5):220–8.

   OpenUrlPubMed
8. 8.↵
   1. Douma S,
   2. Petidis K,
   3. Doumas M,
   4. et al

   . Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study. Lancet 2008;371(9628):1921–6.

   OpenUrlCrossRefPubMedWeb of Science
9. 9.↵
   1. Schirpenbach C,
   2. Segmiller F,
   3. Bidlingmaier M,
   4. et al

   . The diagnosis and treatment of primary hyperaldosteronism in Germany: results on 555 patients from the German Conn Registry. Dtsch Arztebl Int 2009;106(18):305–11.

   OpenUrlPubMed
10. 10.↵
    1. Fogari R,
    2. Preti P,
    3. Zoppi A,
    4. Rinaldi A,
    5. Fogari E,
    6. Mugellini A

    . Prevalence of primary aldosteronism among unselected hypertensive patients: a prospective study based on the use of an aldosterone/renin ratio above 25 as a screening test. Hypertens Res 2007;30(2):111–7.

    OpenUrlCrossRefPubMedWeb of Science
11. 11.↵
    1. Lim PO,
    2. Rodgers P,
    3. Cardale K,
    4. Watson AD,
    5. MacDonald TM

    . Potentially high prevalence of primary aldosteronism in a primary-care population. Lancet 1999;353(9146):40.

    OpenUrlPubMedWeb of Science
12. 12.↵
    1. Westerdahl C,
    2. Bergenfelz A,
    3. Isaksson A,
    4. Nerbrand C,
    5. Valdemarsson S

    . Primary aldosteronism among newly diagnosed and untreated hypertensive patients in a Swedish primary care area. Scand J Prim Health Care 2011;29(1):57–62.

    OpenUrlPubMedWeb of Science
13. 13.↵
    1. Seiler L,
    2. Reincke M

    . The aldosterone to renin ratio in secondary hypertension. Herz 2003;28(8):686–91.

    OpenUrlPubMed
14. 14.↵
    1. Rossi GP,
    2. Seccia TM,
    3. Pessina AC

    . Primary aldosteronism. Part I. Prevalence, screening, and selection of cases for adrenal vein sampling. J Nephrol 2008;21(4):447–54.

    OpenUrl
15. 15.↵
    1. Rosendorff C

    . Spironolactone for all hypertensive patients? J Hypertens 2010;28(1):13–4.

    OpenUrlPubMed
16. 16.↵
    1. Kaplan NM

    . Deja vu for primary aldosteronism. Lancet 2008;371(9628):1890–1.

    OpenUrlCrossRefPubMedWeb of Science
17. 17.↵
    1. Rossi GP,
    2. Pessina AC,
    3. Heagerty AM

    . Primary aldosteronism: an update on screening, diagnosis and treatment. J Hypertens 2008;26(4):613–21.

    OpenUrlPubMedWeb of Science